PolyPid Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

PolyPid (Nasdaq: PYPD) announced that senior management will participate in two investor conferences in March 2026.

Events include the Citizens 2026 Life Sciences Conference on March 10 (1:40 PM ET, Eden Roc Miami Beach) and the 38th Annual ROTH Conference on March 23 (12:30 PM PT, The Ritz-Carlton Laguna Niguel).

Both will feature fireside chats; investors seeking one-on-one meetings should contact their Citizens or Roth representative. A webcast signup link is provided for the Citizens event.

News Market Reaction – PYPD

+0.94%

1 alert

+0.94% News Effect

On the day this news was published, PYPD gained 0.94%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PETACH TIKVA, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that senior management will participate in two upcoming investor conferences taking place during March 2026.

Citizens 2026 Life Sciences Conference

• Date: March 10, 2026 at 1:40 pm ET
• Location: Eden Roc Miami Beach, Miami Beach, FL
• Format: Fireside chat
• Webcast Signup: https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/bygPbooQTs4VTXiUdoDYrb

Investors who wish to meet with PolyPid management should contact their Citizens representative to request a one-on-one meeting.

38^th Annual ROTH Conference

• Date: March 23, 2026, at 12:30 PM PT
• Location: The Ritz-Carlton, Laguna Niguel, Dana Point, CA
• Format: Fireside chat
  

Investors who wish to meet with PolyPid management should contact their Roth representative to request a one-on-one meeting.

About PolyPid
PolyPid Ltd. (Nasdaq: PYPD) is an innovative biopharmaceutical company dedicated to elevating treatment effectiveness, right where care begins. The Company develops long-acting, controlled-release drugs designed to deliver therapy precisely at the site of care, addressing critical unmet medical needs across a wide and diverse pipeline spanning surgical care, metabolic diseases, and beyond. PolyPid’s lead product, D-PLEX₁₀₀, successfully met its primary and all key secondary endpoints in the landmark Phase 3 SHIELD II trial for the prevention of surgical site infections. Guided by a commitment to precision and innovation, PolyPid is redefining how therapies perform and raise the standard of patient care.

For additional Company information, please visit http://www.polypid.com and follow us on Twitter (X) and LinkedIn.

Company Contact:
PolyPid Ltd.
Ori Warshavsky
908-858-5995
IR@Polypid.com

Investor Relations Contact:
Arx Investor Relations
North American Equities Desk
polypid@arxhq.com

FAQ

When will PolyPid (PYPD) present at the Citizens 2026 Life Sciences Conference?

PolyPid will present on March 10, 2026 at 1:40 PM ET. According to the company, the format is a fireside chat at Eden Roc Miami Beach and a webcast signup link is available for remote viewers.

What is the schedule for PolyPid (PYPD) at the 38th Annual ROTH Conference in March 2026?

PolyPid will speak on March 23, 2026 at 12:30 PM PT. According to the company, the session is a fireside chat at The Ritz-Carlton, Laguna Niguel, and one-on-one meetings are arranged via Roth representatives.

How can investors request a one-on-one meeting with PolyPid (PYPD) management at the March 2026 conferences?

Investors should contact their conference representative to request meetings. According to the company, interested investors must reach out to their Citizens or Roth representative to arrange one-on-one sessions.

Is there a webcast for PolyPid's (PYPD) Citizens 2026 presentation and how do I access it?

A webcast signup is available for the Citizens session. According to the company, remote viewers can register via the provided webcast signup link to watch the March 10 fireside chat live.

What topics will PolyPid (PYPD) management likely cover during the March 2026 investor fireside chats?

The company will present recent developments and outlook in a fireside chat format. According to the company, senior management will discuss strategy and progress, with opportunities for investor Q&A and one-on-one meetings.